发明名称 SUSTAINED-RELEASE FORMULATIONS OF TOPIRAMATE
摘要 Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.
申请公布号 US2012321708(A1) 申请公布日期 2012.12.20
申请号 US201213595103 申请日期 2012.08.27
申请人 LIANG LIKAN;WANG HUA;BHATT PADMANABH P.;VIEIRA MICHAEL L.;SUPERNUS PHARMACEUTICALS, INC. 发明人 LIANG LIKAN;WANG HUA;BHATT PADMANABH P.;VIEIRA MICHAEL L.
分类号 A61K31/35;A61K9/24;A61K9/50;A61K9/54;A61P3/10;A61P9/12;A61P17/02;A61P25/00;A61P25/02;A61P25/06;A61P25/08;A61P25/18;A61P25/22;A61P25/28;A61P25/30;A61P37/00 主分类号 A61K31/35
代理机构 代理人
主权项
地址